Why Pacific Premier Bancorp Inc (NASDAQ: PPBI) Stock is a Buy?

242 0 0 0 0 0 (0)

Pacific Premier Bancorp Inc (NASDAQ: PPBI) is one of the largest banks headquartered in Southern California with approximately $11.5 billion in assets. The company conducts business through 33 full-service depository branches. They were founded in 1983 and are headquartered in Irvine, California. PPBI has shown very impressive revenue growth which greatly exceeded the industry average of 13.9%. Since the same quarter a year ago, revenue has grown by 73.5%. 

Register now for the world's best investment ideas

The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and the Commercial Banks industry average. Moreover, the company recently announced a company stock repurchase program, which authorizes the repurchase of up to $100 million of the company’s common stock. These are just some of the reasons Pacific Premier Bancorp (NASDAQ:PPBI) stock has been moving up on the Hade Platform Top 100 investment grade list. 

Over the past week, Pacific Premier Bancorp investment grade on the Hade Platform has risen steadily, making it a Top 100 stock. Ironically, this stability in overall rating happens during a time when the overall market is falling, and as our investment grades as an average have consistently declined for the last four months, effectively predicting a correction.

With overall investment grades still lower, we suggest holding large sums of cash and being very selective when making investment decisions. According to PPBI stock’s current grade, it might very well be one of those selective opportunities. Why should you trust our ratings? The Hade Platform has proven over the course of three years through the application of DLAs and artificial intelligence that it consistently outperforms Wall Street consensus estimates (63%) and major benchmarks such as the S&P 500 (250%). Access our premium services and start beating the market.

Free users on Hade Platform can build a watchlist of stocks and access investment grades from our database of more than 4,000 securities. Premium members can access the platform to get an instant look at which stocks rate highest for value, growth, dividend, and which have the greatest short-term momentum, thereby allowing members to identify areas of opportunity. Premium services include interest trends, risk analysis, machine learning predictions, Top 100 stocks, MatriX Portfolio and more.

Register now for the world's best investment ideas


Comments (0)

Recent Updates

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Healthcare Total Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Helathcare Other of which Gold Bond Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Polio/Pertussis/Hib Vaccines (incl. Hexaxim/Hexyon, Pentacel, Pentaxim and Imovax) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Influenza Vaccines (incl. Vaxigrip, Fluzone HD, Fluzone, Flublok) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Meningitis/Pneumo Vaccines (incl. Menactra) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Adult Booster Vaccines (incl. Adacel) Revenue